Funtleyder Leslie D.
Officer, Director at Applied Therapeutics, Inc.
- Sold, on record
- $5.1M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Mar 4, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Applied Therapeutics, Inc.Officer, Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Applied Therapeutics, Inc.UnusualJun 25, 2020 2020
Sold 20,000 shares at $42.43 ($849k)
Funtleyder Leslie D., Director
Sold 53.8% of holdings ($1.6M position)17,148 shares left1.3x usual sizeFiling
- 2 Form 4 sale Applied Therapeutics, Inc.UnusualAug 24, 2020 +60 days
Sold 13,539 shares at $23.42 ($317k)
Funtleyder Leslie D., Director
Sold 36.4% of holdings ($870k position)23,609 shares left0.8x usual sizeFiling
- 3 Form 4 sale Applied Therapeutics, Inc.UnusualOct 2, 2020 +39 days
Sold 30,000 shares at $20.07 ($602k)
Funtleyder Leslie D., Director
Sold 63.6% of holdings ($946k position)17,148 shares left2x usual sizeFiling
- 4 Form 4 sale Applied Therapeutics, Inc.No planMar 14, 2024 +1259 days
Sold 28,727 shares at $5.39 ($155k)
Funtleyder Leslie D., Chief Financial Officer
No 10b5-1 planSold 8.5% of holdings ($1.8M position)308,421 shares leftFirst sale on recordFiling
- 5 Form 4 sale Applied Therapeutics, Inc.No planJun 6, 2024 +84 days
Sold 16,980 shares at $4.32 ($73k)
Funtleyder Leslie D., Chief Financial Officer
No 10b5-1 planSold 5.5% of holdings ($1.3M position)291,441 shares leftFiling
- 6 Form 4 sale Applied Therapeutics, Inc.No planAug 22, 2024 +77 days
Sold 13,530 shares at $5.83 ($79k)
Funtleyder Leslie D., Chief Financial Officer
No 10b5-1 planSold 4.6% of holdings ($1.7M position)277,911 shares leftFiling
- 7 Form 4 sale Applied Therapeutics, Inc.No planFeb 6, 2025 +168 days
Sold 22,950 shares at $0.61 ($14k)
Funtleyder Leslie D., Officer, Director
No 10b5-1 planSold 5.4% of holdings ($261k position)404,961 shares left1.4x usual sizeFiling
- 8 Form 4 sale Applied Therapeutics, Inc.No planMar 4, 2025 +26 days
Sold 14,502 shares at $0.44 ($6k)
Funtleyder Leslie D., Officer, Director
No 10b5-1 planSold 3.6% of holdings ($178k position)390,459 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Mar 6, 2025 | Applied Therapeutics, Inc. | Officer, Director | Form 4 sale | 14,502 | $6k | 3.6% | No plan | SEC |
| Feb 6, 2025 | Feb 7, 2025 | Applied Therapeutics, Inc. | Officer, Director | Form 4 sale | 22,950 | $14k | 5.4% | No plan | SEC |
| Aug 22, 2024 | Aug 23, 2024 | Applied Therapeutics, Inc. | Chief Financial Officer | Form 4 sale | 13,530 | $79k | 4.6% | No plan | SEC |
| Jun 6, 2024 | Jun 10, 2024 | Applied Therapeutics, Inc. | Chief Financial Officer | Form 4 sale | 16,980 | $73k | 5.5% | No plan | SEC |
| Mar 14, 2024 | Mar 18, 2024 | Applied Therapeutics, Inc. | Chief Financial Officer | Form 4 sale | 28,727 | $155k | 8.5% | No plan | SEC |
| Oct 2, 2020 | Oct 5, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 30,000 | $602k | 63.6% | Unusual | SEC |
| Aug 24, 2020 | Aug 25, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 13,539 | $317k | 36.4% | Unusual | SEC |
| Jun 25, 2020 | Jun 25, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 20,000 | $849k | 53.8% | Unusual | SEC |
| Jun 18, 2020 | Jun 22, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 7,498 | $340k | 30.4% | Unusual | SEC |
| Jun 17, 2020 | Jun 17, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 9,502 | $421k | 27.8% | Unusual | SEC |
| Jun 10, 2020 | Jun 10, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 17,000 | $745k | 49.8% | Unusual | SEC |
| Jun 4, 2020 | Jun 4, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 15,000 | $675k | 46.7% | Unusual | SEC |
| May 29, 2020 | Jun 1, 2020 | Applied Therapeutics, Inc. | Director | Form 4 sale | 18,453 | $835k | 51.8% | Unusual | SEC |